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Abstract
Background: Advanced glycation end-products (AGEs) play a significant role in the development and progression
of vascular complication in diabetes. Anthocyanin has been recently reported to possess antiglycating activity. This
study aimed to determine whether a naturally occurring anthocyanin, cyanidin-3-rutinoside (C3R) inhibits
methylglyoxal (MG) induced protein glycation and oxidative protein and DNA damage.
Methods: C3R (0.125–1 mM) was incubated with bovine serum albumin and MG (1 mM) for 2 weeks. The
formation of fluorescent AGEs was measured by using spectrofluorometer and thiol group content were used to
detect protein oxidative damage. Gel electrophoresis was used to determine whether C3R (0.125–1 mM) reduced
DNA strand breakage in a glycation model comprising lysine, MG and/or Cu2+. The generation of superoxide anions
and hydroxyl radicals were detected by the cytochrome c reduction assay and the thiobarbituric acid reactive
substances assay. MG-trapping capacity was assessed by high performance liquid chromatography (HPLC).
Results: C3R (0.25–1 mM) reduced the formation of fluorescent AGEs and depleted protein thiol groups in bovine
serum albumin mediated by MG. At 1 mM C3R inhibited oxidative DNA damage in the glycation model (p < 0.05)
and at 0.5–1 mM prevented Cu2+ induced DNA strand breakage in the presence of lysine and MG. The findings
showed that C3R reduced the formation of superoxide anion and hydroxyl radicals during the glycation reaction of
MG with lysine. C3R directly trapped MG in a concentration and time dependent manner (both p < 0.001).
Conclusions: These findings suggest that C3R protects against MG-induced protein glycation and oxidative
damage to protein and DNA by scavenging free radicals and trapping MG.
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Background
Methylglyoxal (MG) is recognized as the most react-
ive glycating agent, generated during glycation and
endogenously via carbohydrate, lipid and protein
metabolism, especially during the glycolysis pathway
[1, 2]. Whilst the glyoxalase defense system converts
the damaging MG into D-lactate via the glyoxalase
enzyme complex, elevated tissue and plasma levels of
MG are commonly observed in diabetes [3, 4].
Methylglyoxal hydroimidazolone (MG-H1) is reported
to be the most abundant MG-derived AGE modifica-
tion in vivo leading to protein dysfunction [5]. The
interaction of AGEs with a receptor for AGEs
(RAGE) triggers signal transduction by activation of
the MAPK pathway, resulting in reactive oxygen spe-
cies (ROS) overproduction and inflammation [6]. The
glycation reaction of amino acids with MG directly
generates ROS, causing damage to cellular protein
and DNA [7–10]. In particular, oxidative damage of
DNA is associated with the development of several
pathologies, including physiological ageing, metabolic
syndrome, diabetes, cancer and cardiovascular dis-
eases [11–13].
MG has been recognized as a potential target for inter-
vention and novel pharmacological strategies are being
developed to limit its accumulation and minimize its
detrimental effects. Of these strategies, the ability for
some AGE inhibitors to trap MG has received consider-
able interest [14]. The early clinical trials with amino-
guanidine (AG) showed great promise as an AGEs
inhibitor. However, studies in people with diabetic ne-
phropathy were terminated following safety and efficacy
concerns [15, 16]. Alternatively, studies on AGE inhibi-
tors from natural products show more promise to com-
bat AGE-associated diseases by scavenging free radicals,
or by directly trapping MG. In this regard, pyridox-
amine, a form of naturally occurring vitamin B6 and in-
ducer of glyoxalase enzyme expression -isothiocyanates
and sulforaphanes found in cruciferous vegetables, have
been reported to have some promise [17, 18]. In particu-
lar, anthocyanins, the colourful pigment in various fruits
and vegetables reduced ROS generation in human
HepG2 cells exposed to a high glucose environment
[19]. This could explain, in part their biological effective-
ness as anti-oxidant, anti-carcinogenic, anti-microbial
and anti-inflammatory agents and their role in amelior-
ating hyperglycemia by improving insulin sensitivity via
the cAMP-activated protein kinase pathway in diabetic
mice [20–23]. A derivative of anthocyanin, cyanidin-3-
rutinoside (C3R), maybe particularly important as it de-
lays postprandial glycemia by inhibiting α-glucosidase
and pancreatic α-amylase which play an important role
in glucose metabolism [24–26]. Most recently, C3R
inhibited ribose-, fructose-, glucose- and galactose-
induced protein glycation and oxidation in vitro [27].
Collectively these findings suggest that C3R may prevent
MG-induced AGEs formation and oxidative protein and
DNA damage which have not been investigated
previously.
This study aimed to determine whether C3R inhibited
MG-induced protein glycation (formation of AGEs) and
oxidation (depletion of thiol groups) in vitro, and re-
duced MG/lysine-induced DNA damage using a plasmid
DNA assay. To investigate possible mechanisms of ac-
tion, we evaluated the role of C3R in reducing the gener-
ation of superoxide anion and hydroxyl radicals as well
as direct scavenging of the MG. Due to the complexity
of the glycation cascade, in vitro models were used as
they enabled identification of the pathways of action.
Methods
Chemicals and Reagents
Bovine serum albumin (BSA) fraction V was purchased
from Fisher scientific (Hudson, NH, USA). 40 % solution
methylglyoxal (MG), 5,5′-dithiobis (2-nitrobenzoic acid)
(DTNB), o-phenylenediamine (o-PD), 5-methylquinoxaline
(5-MQ), 2-deoxy-D-ribose, 2-thiobarbituric acid (TBA), L-
cysteine and aminoguanidine hydrochloride (AG) were pur-
chased from Sigma (St. Louis, MO, USA). L-lysine hydro-
chloride was purchased from Himedia (L.B.S. Marg, MB,
India). Trichloroacetic acid, methanol (gradient grade for li-
quid chromatography) and guanidine hydrochloride were
purchased from Merck (Darmstadt, Germany). Cytochrome
c was obtained from Affymetrix (Santa Clara, CA, USA).
Cyanidin-3-rutinoside chloride was synthesized from
quercetin-3-rutinoside according to a previous study [28].
Bovine serum albumin (BSA)-methylglyoxal assay
The glycated BSA was generated according to a previ-
ous study [29]. In brief, 10 mg/mL of BSA was incu-
bated with 1 mM MG in 0.1 M phosphate buffered-
saline (PBS, pH 7.4) containing 0.02 % sodium azide
in the presence or absence of C3R (0.125–1 mM) or
AG (1 mM) at 37 °C for 1 and 2 weeks. PBS was
used as a blank and dimethylsulfoxide (DMSO) at a
final concentration 4 % was used as solvent to dis-
solve C3R. The formation of fluorescent AGEs was
determined using a spectrofluorometer (Perkin Elmer®,
Finland) at excitation wavelength of 355 nm and
emission wavelength of 460 nm. The results were
expressed as percentage of inhibition:
Inhibition of fluorescent AGEs %ð Þ
¼ FC‐FCBð Þ‐ FS‐FSBð Þ= FC‐FCBð Þð Þ½   100
FC was fluorescence intensity of MG with BSA and
FCB were the fluorescence intensity of blank. FS and FSB
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were the fluorescence intensity of C3R or AG with BSA/
MG and blank, respectively.
Determination of thiol group content
Thiol groups in glycated BSA were measured after 1 and
2 weeks of incubation according to the Ellman assay
[30]. Briefly, BSA samples (10 μL) were mixed with
2.5 mM DTNB (90 μL) for 15 min. The absorbance was
measured at 412 nm. The free thiol concentration was
calculated by using a standard curve of L-cysteine.
Analysis of DNA strand breaks
The cleavage of plasmid DNA was analyzed according
to a previous report [9]. Briefly, pUC19 plasmid DNA
was purified from Escherichia coli (E. coli) cultures
using a QIAprep®spin miniprep kit (Santa Clarita,
USA). Plasmid DNA (250 ng) was incubated with
50 mM lysine, 50 mM MG, and 0.125–1 mM C3R
with or without 300 μM Cu2+ at 37 °C for 3 h. Sam-
ples were frozen immediately at −20 °C to stop reac-
tions. After 90 min, the plasmid DNA was mixed
with DNA loading dye and then resolved by 0.8 %
agarose gel electrophoresis at 80 V in TBE buffer for
60 min. Plasmid DNA fragments were visualized and
photographed by a Gel Doc imager (Syngene, UK).
The relative amounts of supercoiled (SC) and open
circular (OC) DNA was quantified by the intensities
of the band obtained using GeneTools software (Syn-
gene, UK) and the percentage of opened circular
DNA (% OC) was calculated using the following
equation. The results were expressed as relative %
OC after subtracting by %OC of control (DNA alone).
%OC ¼ Intensity of OC
Intensity of OCþ SC 100
Determination of superoxide anions
The level of superoxide anions was determined by meas-
urement of cytochrome c reduction assay according to a
previous method [9]. In brief, 10 mM lysine and 10 mM
MG was incubated in the presence or absence of C3R at
concentration 0.125–1 mM. The reduction rate of cycto-
chrome c was measured at room temperature using a
spectrophotometer at 550 nm at 10 min intervals for
50 min. The level of reduced cytochrome c was calcu-
lated based on the extinction coefficient for cytochrome
c (ε = 27,700 M−1cm−1).
Determination of hydroxyl radicals
Thiobarbituric acid reactive substances (TBARS) assay
was used to evaluate the level of hydroxyl radicals ac-
cording to a previously described method [31]. Briefly,
the reaction mixture (0.2 mL total volume) containing
10 mM lysine, 10 mM MG, and 20 mM 2-deoxy-d-ri-
bose was incubated at 37 °C with or without C3R
(0.125–1 mM). After 3 h, 0.2 mL PBS and 0.2 mL TCA
(2.8 % w/v) was added to the reaction mixture, followed
by 0.2 mL thiobarbituric acid (TBA). The solution was
boiled at 100 °C for 10 min and then cooled to room
temperature. The degradation of 2-deoxy-d-ribose was
measured at a wavelength 532 nm using a spectropho-
tometer. Hydroxyl radicals were expressed as the level of
TBARS which was quantified by using standard curve of
malondialdehyde.
Determination of MG-trapping ability
C3R was incubated with MG at various molar ratios
including 0.25:1, 0.5:1, 1:1, 2:1, 4:1 and 16:1 in 0.1 M
PBS, pH 7.4. AG was used as positive control to in-
cubate with MG at 1:1 molar ratio. The reaction mix-
tures were incubated at 37 °C for 1 and 24 h. After
the incubation, 20 mM o-phenylenediamine (o-PD)
was added to stop the reaction by converting the
remaining MG into 2-methylquinoxaline (2-MQ). The
quantification of MG was based on the determination
of its derivative compound (2-MQ) using HPLC [32].
An Inersil-ODS3V C18 column (150 × 4.6 mm i.d.; 5-
μm particle size) was used along with a LC-10 AD
pump, SPD-10A UV-vis detector and LC-Solution
software (Shimadzu Corp., Kyoto, Japan). The absorb-
ance was recorded at 315 nm and the injection vol-
ume was 10 μL. An isocratic program was performed
with 50 % HPLC grade water and 50 % methanol (v/
v) with a constant flow rate set at 1 mL/min. The
total running time was 14 min and the internal stand-
ard was 0.06 % (v/v) 5-methylquinoxaline (5-MQ) in
methanol. The percentage of MG reduction was cal-
culated using the equation below:




Data are presented as the arithmetic means ± SEM for
each treatment group (n = 3). The effect of C3R on the
formation of AGEs, protein oxidation, DNA strand
break and MG-induced generation of hydroxyl radical
was analyzed by one-way ANOVA. The effect of C3R on
MG-induced generation of superoxide anion was deter-
mined by two-way repeated measures ANOVA. The ef-
fect of C3R on MG-trapping ability was determined by a
two-way ANOVA. Differences between treatments were
analyzed by a Tukey post hoc test. These analyses were
performed using SPSS Statistics 17.0 (SPSS Inc., Chi-
cago, IL, USA). A P value of less than 0.05 was taken as
the criterion of significance.
Thilavech et al. BMC Complementary and Alternative Medicine  (2016) 16:138 Page 3 of 10
Results
C3R and the formation of AGEs
The addition of MG to BSA in the BSA/MG assay
caused a 5-fold increase in the formation of fluores-
cent AGEs (Fig. 1). This MG induced glycation of
BSA was reduced when C3R was added at a level of
0.25 mM or above (p < 0.05) and the reduction was
greatest when C3R was added at 1 mM (65 %) such
that glycation levels were similar to when no MG was
present. The addition of AG as a positive control
inhibited the formation of fluorescent AGEs by a
similar amount as 1 mM C3R.
C3R and protein oxidation
Incubation of BSA with MG dramatically reduced the
number of thiol groups by 95 %. This reduction in thiol
groups was impaired by C3R at concentrations of
0.125 mM or greater (Fig. 2). At the highest concentration
of C3R (1 mM) tested, there were 33 % more thiol groups
than BSA/MG (p < 0.05), an effect that was greater than
that seen when BSA/MG was incubated with AG (1 mM).
C3R and MG-induced DNA strand breakage
The addition of lysine, MG, Cu2+ or C3R to plasmid
DNA did not cause DNA cleavage, as plasmid DNA
Fig. 2 The effects of cyanidin-3-rutinoside (C3R) and aminoguanidine (AG) modulating the level of protein thiol groups in the BSA/methylglyoxal
(MG) assay. The results are presented as mean ± SEM (n = 3). Significance is shown in groups that do not share a common letter (p < 0.05)
Fig. 1 The effects of cyanidin-3-rutinoside (C3R) and aminoguanidine (AG) modulating the formation of fluorescent glycated protein in the BSA/
methylglyoxal (MG) assay. The results are presented as mean ± SEM (n= 3). Significance is shown in groups that do not share a common letter (p< 0.05)
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remained in the supercoiled (SC) form (Fig. 3a). The
addition of MG and lysine to plasmid DNA increased
strand breakage of plasmid DNA by 69 % by increasing
intensity of the open circular (OC) band (Fig. 3b) and
was reduced by 26 % at the highest dose of C3R (1 mM)
(Fig. 4a). In the presence of Cu2+, the cleavage of plas-
mid DNA was 77 % higher than lysine/MG without Cu2
+ (Fig. 3c) and was markedly reduced by 12 % and 18 %
at 0.5 and 1 mM of C3R, respectively (Fig. 4b).
C3R and MG-induced generation of superoxide anion and
hydroxyl radicals
MG increased the formation of superoxide anion forma-
tion (as measured by reduced cytochrome c) over the
50 min incubation period which was significantly higher
when MG was incubated with lysine (p < 0.001). The ele-
vation of superoxide anion production caused by lysine/
MG was prevented by all concentrations of C3R
(Fig. 5a).
The lysine/MG induced generation of hydroxyl radi-
cals (as measured by TBARS) was reduced when C3R
was added at the level of 0.5 mM or above (Fig. 5b). The
highest concentration of C3R (1 mM) resulted in a 20 %
inhibition of hydroxyl radical generation.
C3R and MG trapping ability
An evaluation of direct MG-trapping capacity was car-
ried out in order to investigate whether C3R could dir-
ectly scavenge MG. The percentage of MG-trapping
efficiency of C3R was consistent with the increased con-
centration of C3R and time of incubation (p < 0.001).
The increase in incubation time from 1 to 24 h in-
creased efficiency of C3R to scavenge MG by 2-fold. In
addition, the MG trapping ability of C3R was increased
as the molar ratio of C3R to MG increased. The equal
molar ratio of C3R to MG resulted in 21 % and 45 %
MG-trapping capacity after 1 and 24 h of incubation.
AG showed a higher trapping capacity compared to C3R
as it trapped 90 and 95 % of MG when incubated with
MG (1:1 molar ratio) for 1 and 24 h, respectively
(Table 1).
Discussion
The development of macrovascular and microvascular
diabetic complications is associated with the formation
and accumulation of advanced glycation end products
(AGEs) [33, 34]. There is an important need to identify
approaches that may prevent their formation [35, 36]
and this study shows for the first time that cyanidin-3-
rutinoside (C3R) effectively inhibited dicarbonyl inter-
mediate methylglyoxal (MG)-derived AGEs formation at
an immediate stage of the glycation process. C3R finally
suppressed the formation of fluorescent AGEs and non-
fluorescent AGEs in advanced stage of glycation process.
This inhibitory activity of C3R on protein glycation was
just as effective as aminoguanidine (AG) when highest
dose (1 mM) was provided. These findings extend previ-
ous research which showed that C3R inhibited ribose-,
fructose-, glucose- and galactose-induced AGEs forma-
tion during the initial stage of glycation associated with
the reduction of Amadori product fructosamine [27].
Furthermore, berry and grape extracts containing antho-
cyanin also inhibited the formation of AGEs in an in
vitro model involving fructose, MG and BSA [37]. It is
likely that these protein glycation protective effects of
the fruit extracts may be largely due to C3R content as it
is the predominant anthocyanin component [38, 39].
These findings, taken together, suggest that C3R poten-
tially impairs initiation and intermediate stages of pro-
tein glycation and supports the need for efficacy and
bioavailability studies of C3R in animals and humans.
The effectiveness of C3R in reducing the formation of
AGEs can be explained in part by the effect of C3R on
Fig. 3 The effects of cyanidin-3-rutinoside (C3R) on DNA cleavage-
mediated by glycation of lysine with methylglyoxal (MG) in the absence
or presence of Cu2+. The major band corresponds to supercoiled form
(SC), and damaged plasmid DNA is represented as opened circular form
(OC). pUC19 DNA (0.25 μg) was incubated with the following: a Lane 1,
DNA alone; Lane 2, 50 mM lysine; Lane 3, 50 mM MG; Lane 4, 300 μM
CuSO4; Lane 5, 1 mM C3R. b Lane 1, DNA alone; Lane 2, 50 mM lysine +
50 mM MG; Lane 3, 50 mM lysine + 50 mM MG+ 0.125 mM C3R; Lane 4,
50 mM lysine + 50 mM MG+ 0.25 mM C3R; Lane 5, 50 mM lysine +
50 mM MG+ 0.5 mM C3R; Lane 6, 50 mM lysine + 50 mM MG+ 1 mM
C3R. c Lane 1, DNA alone; Lane 2, 50 mM lysine + 50 mM MG+ 300 μM
Cu2+; Lane 3, 50 mM lysine + 50 mM MG+ 300 μM Cu2+ + 0.125 mM
C3R; Lane 4, 50 mM lysine + 50 mM MG+ 300 μM Cu2+ + 0.25 mM C3R;
Lane 5, 50 mM lysine + 50 mM MG+ 300 μM Cu2+ + 0.5 mM C3R; Lane
6, 50 mM lysine + 50 mM MG+ 300 μM Cu2+ + 1 mM C3R
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scavenging superoxide anion and hydroxyl radicals. In
the current study, we showed that in the presence of ly-
sine and MG, C3R reduced the level of TBARS forma-
tion at concentrations of 0.25 mM or greater and
maintained the reduced form of cytochrome c at back-
ground levels. C3R also prevented the depletion of thiol,
a marker of protein oxidation with higher potency than
AG when provided at an equal concentration (1 mM) in
BSA/MG (1 mM) system. In previous report, the ROS
production during glycation process in BSA/MG system
showed potent to induce DNA strand breakage when
used the higher concentration of MG (20 mM) for 10
and 21 days of incubation [40]. Protein cross-linking
mediated by MG generates free radicals during this reac-
tion including the MG-radical anion and cross-linked rad-
ical cation (MG-protonated cation) [41]. The MG-
protonated cation is a precursor of fluorescent AGEs
while MG-radical anions could donate an electron to oxy-
gen molecule to generate a superoxide anion and hydroxyl
radical [9, 10, 42]. The presence of a transition metal ion
copper could stimulate the Fenton-like reaction to pro-
duce more highly reactive hydroxyl radicals that play an
important role in mechanism of oxidative DNA strand
breakage [11]. The ability of phytochemical com-
pounds on the prevention of MG-induced protein gly-
cation and DNA damage related to free radical
Fig. 4 The effect of cyanidin-3-rutinoside (C3R) modulating % open circular (OC) form of plasmid DNA in lysine/methylglyoxal (MG)-induced DNA
strand breakage in the absence (a) and presence of Cu2+ (b). The results are presented as mean ± SEM (n = 3). Significance is shown in groups
that do not share a common letter (p < 0.05)
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scavenging activity has been reported [31, 42, 43].
Anthocyanin-rich extract containing high concentra-
tion of C3R also exhibits potent antioxidant activity
[44, 45] and it is suggested that C3R may act as free
radical scavenger to prevent oxidative damage of pro-
tein and DNA. These studies support previous reports
that C3R inhibited the production of a secondary
product of oxidation malonaldehyde from the degrad-
ation of 2-deoxyribose unit in DNA mediated by Fen-
ton’s reagent as well as decreased ROS production
and DNA damage in hydrogen peroxide-simulated
RAW 264.7 murine macrophage cell [46, 47].
The current study demonstrated that C3R was able
to directly trap MG which explains, in part its action
Fig. 5 The effects of cyanidin-3-rutinoside (C3R) modulating the production of superoxide anion (a) and hydroxyl radicals (b) in lysine/methylglyoxal
(MG)-induced glycation. The results are presented as mean ± SEM (n = 3). Significance is shown in groups that do not share a common letter (p < 0.05)
Table 1 The percentage of methylglyoxal (MG)-trapping ability of cyanidin-3-rutinoside (C3R) and aminoguanidine (AG)
Time
(h)
Molar ratio of C3R:MG Molar ration of AG:MG
0.25:1 0.5:1 1:1 2:1 4:1 16:1 1:1
1 5 ± 0.3 12 ± 1.3 21 ± 2.6 32 ± 2.0 42 ± 2.5 61 ± 1.9 90 ± 3.2
24 9 ± 1.2 21 ± 1.0 45 ± 0.7 57 ± 3.0 73 ± 3.2 89 ± 1.1 95 ± 4.6
The results are presented as mean ± SEM (n = 3)
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in preventing the formation of AGEs and oxidative
protein and DNA damage. The percentage of MG-
trapping ability increased in a concentration dependent
manner and these findings are supported by a previous
study which showed that a purified C3R from blackcur-
rant extract trapped nearly 50 % of MG when it was incu-
bated at a 1:1 ratio. The C3R-mono-MG adduct was
identified as product from the reaction by using liquid
chromatography electrospray ionization mass spectrom-
eter (LC-ESI-MS) [48]. The molecular weight difference
between the adduct (667 m/z) and the original C3R
(595 m/z) is 72 which is same as the molecular weight of
one molecule of MG. It has been reported the addition of
MG on anthocyanin may probably form tautomers with
transformation of carbonyl group of MG to hydroxyl
group [49]. In the previous study, the MG addition reac-
tion reacted with phenolic compounds at carbon atom
with negative electron charge more than −0.24. Therefore,
carbon number 2, 6, 7 and 15 of C3R is the possible loca-
tion for MG addition reaction [48]. Chen et al. demon-
strated the C3R/MG reaction for only 1 h [48] but the
different molar ratio and incubation time between C3R
and MG was evaluated in the current study. The reaction
rate between C3R and MG at 1:1 molar ratio was nearly
2-fold higher when the incubation time was increased
from 1 to 24 h. It suggests that the trapping ability of C3R
is dependent on the concentration and time of incubation.
In addition, flavonoids have also been shown to inhibit
AGEs formation via MG-trapping ability [37, 50–53]
which may be due to their chemical structure that consists
of phenyl ring (A- and B-ring) and heterocyclic ring (C-
ring). The major sites to conjugate with MG are the car-
bon positions at 6 and 8 on the A-ring [51] which is the
same structure present in C3R and may explain their ef-
fectiveness in trapping MG [48].
Conclusion
C3R inhibited MG-induced protein glycation and
oxidation-dependent damage to bovine serum albumin
and prevented lysine/MG-induced oxidative DNA dam-
age. The inhibitory effect of C3R was attributed in part
to its ability to scavenge ROS and directly trap reactive
dicarbonyl MG (Fig. 6). These observations suggest that
C3R may have anti-glycation potential for preventing
diabetic complications.
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